Latest biopharmaceutical Stories
JUPITER, Fla., March 18, 2014 /PRNewswire/ -- Dyadic International, Inc.
-- ABRAXANE plus gemcitabine approved by the TGA for the first-line treatment of metastatic pancreatic cancer MELBOURNE, Australia, March 18, 2014 /PRNewswire/ -- Australian biopharmaceutical
CAMBRIDGE, England, March 16, 2014 /PRNewswire/ -- Kymab, a monoclonal antibody biopharmaceutical company founded on research from the Wellcome Trust
GHENT, Belgium, March 14, 2014 /PRNewswire/ -- ActoGeniX NV, creator of ActoBiotics(TM), announced today that Bernard Coulie, Chief Executive Officer, will present a company overview at the
MONROVIA, Calif., March 13, 2014 /PRNewswire/ -- Xencor, Inc.
Funding to support clinical development of treatments for rare cholestatic liver diseases and nonalcoholic steatohepatitis SAN DIEGO, March 11, 2014 /PRNewswire/ -- Lumena Pharmaceuticals
LONDON, March 10, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
LONDON, March 6, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
The 2014 BioProcess International Awards celebrate the excellence and innovation developed by those working in the biotherapeutic development and manufacturing industry.
CAMBRIDGE, Mass., Feb.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.